BIO-B (BIO-B) Stock Price & Analysis
BIO-B (BIO-B) rose 0.00% to USD 365.08 as of September 8, 2026 at 09:11 UTC, according to Nexqual real-time market data.
BIO-B last closed at USD 365.08; the session ranged USD 365.08–365.08 on volume of 27 shares. Market capitalization is —, with a 52-week range of USD 244.54–365.08 (NYQ). Source: Nexqual, September 8, 2026 at 09:11 UTC.
Key Statistics (as of September 8, 2026 at 09:11 UTC)
| Price | USD 365.08 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 365.08 |
| Open | USD 365.08 |
| Day Range | USD 365.08 – 365.08 |
| 52-Week Range | USD 244.54 – 365.08 |
| Volume | 27 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (BIO-B)
Nexqual's technical model rates BIO-B "BUY" based on 5 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 09:11 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 327.26) |
| MACD | 11.59 (positive) |
From BIO-B's Latest SEC 10-K Filing (filed 2026-02-13)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MKC-V | McCormick & Company, Incorporat | USD 52.19 | ▼ 2.72% |
| TAP-A | Molson Coors Beverage Company | USD 47.96 | ▲ 0% |
| WSO-B | Watsco, Inc. | USD 316.05 | ▲ 0% |
| GEF-B | Greif, Inc. Corporation | USD 108.62 | ▲ 1.21% |
| LEN-B | Lennar Corporation | USD 82.17 | ▲ 0.02% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:11 UTC. This page is informational and not investment advice.